Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02634944 · ClinicalTrials.gov registry record · NA

The Use of the VOMS Tool With Military Personnel to Track mTBI Recovery and RTD Status

A NA study of Mild Traumatic Brain Injury, sponsored by University of Pittsburgh.

Completed
Registry status
NA
Development phase
452
Enrollment target
1
Study location

NCT02634944: Completed NA study of Mild Traumatic Brain Injury, sponsored by University of Pittsburgh.

NCT02634944 is a NA study of Mild Traumatic Brain Injury that has completed, run by University of Pittsburgh. The registered enrollment target is 452 participants, above the 210-participant average among 43 other Mild Traumatic Brain Injury trials with a reported enrollment target (115% higher). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02634944, a NA study of Mild Traumatic Brain Injury, has completed, sponsored by University of Pittsburgh.

COMPLETED
Registry status
NA
Development phase
452 participants
Enrollment target
1
Study location

Study Summary

The purpose of the proposed project is to determine if the VOMS is an effective screening tool to identify and track recovery of vestibular and ocular motor impairment and symptoms following mTBI, that corpsman-level medical personnel can successfully implement in combat and non-combat environments. A second purpose of the project is to determine if impairment and symptoms on the VOMS is more pronounced following blast compared to blunt mTBI.

Primary Outcome

In-person and telemedicine VOMS (Vestibular Ocular-Motor Screening) training with USASOC medical personnel, followed by repeated VOMS measures to examine reliability of symptom report

Interventions

  • DIAGNOSTIC_TEST Vestibular Ocular Motor Screening Tool (VOMS)

Study Locations (1)

Washington

  • First Special Forces Group - JBLM - Fort Lewis

Trial Details

FieldValue
Enrollment Target 452 participants
Start Date 2018-03-16
Est. Completion 2020-02-29
Phase NA
University of Pittsburgh

1,238 total trials

What the finished NCT02634944 record still lists

NCT02634944 is an interventional study that assigns participants to a tested intervention. The registered 452 participants enrollment target is mid-sized for trials with a published cap, above the 210-participant average among 43 other Mild Traumatic Brain Injury trials with a reported enrollment target (115% higher).

The record links to 1 condition, with Mild Traumatic Brain Injury appearing as the primary indexed condition, and to 1 intervention - of which Vestibular Ocular Motor Screening Tool (VOMS) is the first listed.

NCT02634944 reports a single indexed study location in Washington.

Frequently Asked Questions

What is clinical trial NCT02634944 about?

NCT02634944 is a clinical study titled "The Use of the VOMS Tool With Military Personnel to Track mTBI Recovery and RTD Status". The purpose of the proposed project is to determine if the VOMS is an effective screening tool to identify and track recovery of vestibular and ocular motor impairment and symptoms following mTBI, that corpsman-level medical personnel can successfully implement in combat and non-combat environments....

What is the current status of trial NCT02634944?

This trial is currently completed. It is a NA study. The enrollment target is 452 participants. The study started on 2018-03-16. Estimated completion is 2020-02-29.

What conditions does trial NCT02634944 study?

This clinical trial studies the following conditions: Mild Traumatic Brain Injury.

What interventions are being tested in trial NCT02634944?

The interventions under investigation include: Vestibular Ocular Motor Screening Tool (VOMS) (DIAGNOSTIC_TEST).

Who is sponsoring clinical trial NCT02634944?

This trial is sponsored by University of Pittsburgh, which has 1,238 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT02634944 being conducted?

This trial has 1 study location across Washington. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Mild Traumatic Brain Injury

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT02634944's enrollment target sits among peer trials

452 5th of 43 higher than 39 of 43 other Mild Traumatic Brain Injury trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Mild Traumatic Brain Injury trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT05676255 · 452 participants · Phase 2

    The Breast Cancer Survivors and Partners Online Research Together (SUPORT) Project

  • NCT05703178 · 452 participants · Phase 3

    Web-based Pain Coping Skills Training for Breast Cancer Survivors With AI-Associated Arthralgia

  • NCT03460977 · 453 participants · Phase 1

    A Study of Mevrometostat for Treatment of Relapsed/Refractory SCLC, Castration Resistant Prostate Cancer, and Follicular Lymphoma

  • NCT04708171 · 453 participants

    The PROGRAM-study: Awake Mapping Versus Asleep Mapping Versus No Mapping for Glioblastoma Resections

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT02634944, the US trial registry maintained by the National Library of Medicine. NCT02634944 (mid enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.